All Stories

  1. Hydroxychloroquine and Mortality in SARS-Cov-2 Infection; the HOPECovid- 19 Registry
  2. Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry
  3. Safety of intermediate left main stenosis revascularization deferral based on fractional flow reserve and intravascular ultrasound: A systematic review and meta-regression including 908 deferred left main stenosis from 12 studies
  4. You may stay forever young: An editorial regarding management of heart disease in pregnancy
  5. Self-expandable sirolimus-eluting stents compared to second-generation drug-eluting stents for the treatment of the left main: A propensity score analysis from the SPARTA and the FAILS-2 registries
  6. Major bleeding with old and novel oral anticoagulants: How to manage it. Focus on reversal agents
  7. A meta-analysis of MitraClip combined with medical therapy vs. medical therapy alone for treatment of mitral regurgitation in heart failure patients
  8. Incidence and predictors of bleeding in ACS patients treated with PCI and prasugrel or ticagrelor: An analysis from the RENAMI registry
  9. Meta-Analysis comparing Outcomes of Drug Eluting Stents versus Single and Multi-Arterial Coronary Artery Bypass Grafting
  10. Network meta-analysis comparing iFR versus FFR versus coronary angiography to drive coronary revascularization
  11. Gender-related differences in post-discharge bleeding among patients with acute coronary syndrome on dual antiplatelet therapy: A BleeMACS sub-study
  12. Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: Insights from the RENAMI registry
  13. Another brick in the wall: The impact of ticagrelor use on the incidence of stroke in a large registry
  14. Incidence of thromboembolic events following atrial fibrillation catheter ablation and rate control strategies according to the kind of oral anticoagulation: A systematic review and meta-analysis
  15. Clinical impact of optical coherence tomography findings on culprit plaque in acute coronary syndrome: The OCT-FORMIDABLE study registry
  16. Simplified hybrid algorithms for pressure wire interrogation exploiting advantages of a baseline and contrast Pd/Pa ratio indexes to predict stenosis significance: Insight from the SPARE multicenter prospective study
  17. The EUROpean and Chinese cardiac and renal Remote Ischemic Preconditioning Study (EURO-CRIPS CardioGroup I): A randomized controlled trial
  18. Unmeasured Confounders in Observational Studies Comparing Bilateral Versus Single Internal Thoracic Artery for Coronary Artery Bypass Grafting: A Meta‐Analysis
  19. How Digital Transformation is Reshaping the Manufacturing Industry Value Chain: The New Digital Manufacturing Ecosystem Applied to a Case Study from the Food Industry
  20. Which is the best antiaggregant or anticoagulant therapy after TAVI? A propensity-matched analysis from the ITER registry. The management of DAPT after TAVI
  21. Planned angiographic control versus clinical follow-up for patients with unprotected left main stem stenosis treated with second generation drug-eluting stents: A propensity score with matching analysis from the FAILS (failure in left main with second gen
  22. Cardiovascular disease in patients with HIV
  23. Impact of design of coronary stents and length of dual antiplatelet therapies on ischaemic and bleeding events: a network meta-analysis of 64 randomized controlled trials and 102 735 patients
  24. Culprit plaque characteristics in younger versus older patients with acute coronary syndromes: An optical coherence tomography study from the FORMIDABLE registry
  25. Left main occlusion secondary to infective endocarditis vegetation: “The unusual suspect”
  26. Incidence and Management of Restenosis After Treatment of Unprotected Left Main Disease With Second-Generation Drug-Eluting Stents (from Failure in Left Main Study With 2nd Generation Stents–Cardiogroup III Study)
  27. Comment on the EXPLORE Trial
  28. Angiographic Follow-Up in Patients With Coronary Artery Disease
  29. Three Arterial Grafts Improve Late SurvivalClinical Perspective
  30. Impact of an optical coherence tomography guided approach in acute coronary syndromes: A propensity matched analysis from the international FORMIDABLE-CARDIOGROUP IV and USZ registry
  31. Outcomes of patients with low-pressure aortic gradient undergoing transcatheter aortic valve implantation
  32. Tears are words that heart cannot express
  33. statins and HIV:
  34. Psychiatric Disorders In Takotsubo Cardiomyopathy Compared With Acute Coronary Syndrome Patients
  35. Moving from Evidence to Action
  36. A meta-analysis investigating incidence and features of stroke in HIV-infected patients in the highly active antiretroviral therapy era
  37. Supraventricular Arrhythmias in Patients With Pulmonary Arterial Hypertension
  38. All that glitters ain't gold! A case of embolic STEMI demonstrated by OCT
  39. Much ado about nothing: a case of diffuse vasospam without demonstration of plaque at optical coherence tomography in an STEMI patient:
  40. Radial strength and expansion of scaffold struts remain a concern when considering a PCI with bioresorbable vascular scaffold
  41. Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis
  42. Meta-Analysis of the Usefulness of Mitraclip in Patients With Functional Mitral Regurgitation
  43. Sixty-day readmission rate after percutaneous coronary intervention: predictors and impact on long-term outcomes
  44. Meta-Analysis of Comparison Between Self-Expandable and Balloon-Expandable Valves for Patients Having Transcatheter Aortic Valve Implantation
  45. Accuracy of intravascular ultrasound and optical coherence tomography in identifying functionally significant coronary stenosis according to vessel diameter: A meta-analysis of 2,581 patients and 2,807 lesions
  46. Accuracy of 64-slice coronary computed tomography in patients with tako-tsubo cardiomyopathy
  47. Left anterior descending coronary artery fistula to left ventricle: The revenge of a well treated myocardial infarction in the era of primary percutaneous angioplasty
  48. High prevalence at computed coronary tomography of non-calcified plaques in asymptomatic HIV patients treated with HAART: A meta-analysis
  49. Heart failure in patients with human immunodeficiency virus
  50. Meta-Analysis of Randomized Controlled Trials and Adjusted Observational Results of Use of Clopidogrel, Aspirin, and Oral Anticoagulants in Patients Undergoing Percutaneous Coronary Intervention
  51. A Meta-Analysis of Sex-Related Differences in Outcomes After Primary Percutaneous Intervention for ST-Segment Elevation Myocardial Infarction
  52. Twist and shout during an acute coronary syndrome: Can dynamic changes in ECG predict OCT's findings?
  53. Beta blocker for patients with pulmonary arterial hypertension: A single center experience
  54. β-Blockers in hypertension, diabetes, heart failure and acute myocardial infarction: a review of the literature
  55. Cardiovascular disease in HIV patients: from bench to bedside and backwards
  56. Network meta-analysis for evidence synthesis: What is it and why is it posed to dominate cardiovascular decision making?
  57. The EUROpean and Chinese cardiac and renal Remote Ischemic Preconditioning Study (EURO-CRIPS)
  58. Effect of Gender After Transcatheter Aortic Valve Implantation: A Meta-Analysis
  59. Comparison of Balloon-Expandable Versus Self-Expandable Valves for Transcatheter Aortic Valve Implantation in Patients With Low-Gradient Severe Aortic Stenosis and Preserved Left Ventricular Ejection Fraction
  60. Thirty-day readmission rates after PCI in a metropolitan center in Europe
  61. Impact of residual coronary artery disease on patients undergoing TAVI: A meta-analysis of adjusted observational studies
  62. Management of multivessel coronary disease in STEMI patients: A systematic review and meta-analysis
  63. Accuracy of bleeding scores for patients presenting with myocardial infarction: a meta-analysis of 9 studies and 13 759 patients
  64. Usefulness and Validation of the Survival posT TAVI Score for Survival After Transcatheter Aortic Valve Implantation for Aortic Stenosis
  65. Syncope Risk Stratification Tools vs Clinical Judgment: An Individual Patient Data Meta-analysis
  66. Meta-Analysis of Predictors of All-Cause Mortality After Transcatheter Aortic Valve Implantation
  67. A Gender Based Analysis of Predictors of All Cause Death After Transcatheter Aortic Valve Implantation
  68. Impact of Access on TAVI Procedural and Midterm Follow-Up: A Meta-Analysis of 13 Studies and 10,468 Patients
  69. Prognostic Indicators for Recurrent Thrombotic Events in HIV-infected Patients with Acute Coronary Syndromes: Use of Registry Data From 12 sites in Europe, South Africa and the United States
  70. Is concomitant aspirin helping novel oral anticoagulants? Focus on apixaban
  71. Impact on Prognosis of Periprocedural Myocardial Infarction after Percutaneous Coronary Intervention
  72. Predictors of cardiovascular events in patients with systemic lupus erythematosus (SLE): a systematic review and meta-analysis
  73. RAPSTROM™ First-in-Man Study Long-Term Results of a Biodegradable Polymer Sustained-Release Sirolimus-Eluting Stent in De Novo Coronary Stenoses
  74. Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation
  75. Long-Term Outcomes of Percutaneous Coronary Interventions or Coronary Artery Bypass Grafting for Left Main Coronary Artery Disease in Octogenarians (from a Drug-Eluting stent for LefT main Artery Registry Substudy)
  76. Percutaneous coronary intervention versus coronary artery bypass graft for stable angina: Meta-regression of randomized trials
  77. A Systematic Review and Collaborative Meta-Analysis to Determine the Incremental Value of Copeptin for Rapid Rule-Out of Acute Myocardial Infarction
  78. Impact on Prognosis of Periprocedural Bleeding after TAVI: Mid-Term Follow-Up of a Multicenter Prospective Study
  79. Cardiac remote ischaemic preconditioning reduces periprocedural myocardial infarction for patients undergoing percutaneous coronary interventions: a meta-analysis of randomised clinical trials
  80. COPEPTIN LEVELS IN THE TRIAGE OF PATIENTS PRESENTING TO THE EMERGENCY DEPARTMENT WITH CHEST PAIN: A COLLABORATIVE META-ANALYSIS
  81. Discontinuation of Dual Antiplatelet Therapy Over 12 Months after Acute Coronary Syndromes Increases Risk for Adverse Events in Patients Treated with Percutaneous Coronary Intervention: Systematic Review and Meta-Analysis
  82. Nephropathy after administration of iso-osmolar and low-osmolar contrast media: Evidence from a network meta-analysis
  83. Optimal aspirin dose in acute coronary syndromes: an emerging consensus
  84. Clinical Outcomes With Bioabsorbable Polymer- Versus Durable Polymer-Based Drug-Eluting and Bare-Metal Stents
  85. Shaping an ectatic coronary artery: Stentys implantation
  86. Meta-Analysis Comparing Carvedilol Versus Metoprolol for the Prevention of Postoperative Atrial Fibrillation Following Coronary Artery Bypass Grafting
  87. Impact of Diabetes Mellitus on Early and Midterm Outcomes After Transcatheter Aortic Valve Implantation (from a Multicenter Registry)
  88. The Prognostic Impact of High On-Treatment Platelet Reactivity with Aspirin or ADP Receptor Antagonists: Systematic Review and Meta-Analysis
  89. A Network Meta-Analysis on Randomized Trials Focusing on the Preventive Effect of Statins on Contrast-Induced Nephropathy
  90. Review and Meta-Analysis of Incidence and Clinical Predictors of Anthracycline Cardiotoxicity
  91. Percutaneous coronary intervention in nonagenarian
  92. Drugs for attention deficit–hyperactivity disorder do not increase the mid-term risk of sudden death in children: A meta-analysis of observational studies
  93. Can we predict which patients with ST-elevation myocardial infarction benefit most from radial access? Evidence from frequentist and Bayesian meta-regressions of randomized trials
  94. Clopidogrel is safer than ticagrelor in regard to bleeds: A closer look at the PLATO trial
  95. Choosing the best first line oral drug agent in patients with pulmonary hypertension: Evidence from a network meta-analysis
  96. Drug-eluting balloons for peripheral artery disease: A meta-analysis of 7 randomized clinical trials and 643 patients
  97. Incidence and clinical features of stroke in HIV patients in HAART era: a meta-analysis
  98. Risk prediction in patients with STEMI undergoing primary PCI: an observational study
  99. Prevalence of cardiovascular risk factors in long-term survivors of childhood cancer
  100. HIV-infected patients with acute coronary syndromes: thrombotic events or plaque progression? An international contemporary registry
  101. Frailty assessment as a prognostic tool in elderly acute coronary syndrome patients to identify those approaching end-of-life: results from prospective multicenter fate-acs study
  102. Coronary computed tomographic angiography for detection of coronary artery disease in patients presenting to the emergency department with chest pain: a meta-analysis of randomized clinical trials
  103. Long term outcomes in patients who underwent percutaneous coronary intervention on left main coronary artery according to clinical and angiographic scores
  104. A mid-term follow-up of a multicentre prospective study about life-threatening and major bleedings after TAVI
  105. CD4+ lymphocyte count predicts recurrent thrombotic events in HIV-infected patients with acute coronary syndromes
  106. Mid-term prognostic value of coronary artery disease in patients undergoing transcatheter aortic valve implantation: a meta-analysis of adjusted observational results
  107. Could clinical variables of patients undergoing surgical or percutaneous coronary revascularization be useful to make a better choiche? a meta-regression of randomized clinical trials
  108. 30days and midterm outcomes of patients undergoing percutaneous replacement of aortic valve according to their renal function: A multicenter study
  109. Gender differences in patients undergoing TAVI: a multicentre study
  110. Incidence, etiology and predictors of adverse outcomes in 43,315 patients presenting to the Emergency Department with syncope: An international meta-analysis
  111. Incidence and predictors of coronary stent thrombosis: Evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses
  112. English
  113. Meta-analysis of coronary CT angiography in the emergency department: reply
  114. Cardiac dysfunction in pauci symptomatic human immunodeficiency virus patients: a meta-analysis in the highly active antiretroviral therapy era
  115. Benefits of   blockers in patients with heart failure and reduced ejection fraction: network meta-analysis
  116. A Novel Closed-Chest Porcine Model of Chronic Ischemic Heart Failure Suitable for Experimental Research in Cardiovascular Disease
  117. Atherosclerotic coronary plaque regression and the risk of adverse cardiovascular events: A meta-regression of randomized clinical trials
  118. Coronary computed tomographic angiography for detection of coronary artery disease in patients presenting to the emergency department with chest pain: a meta-analysis of randomized clinical trials
  119. Echocardiographic Evaluation of Right Ventricular Stroke Work Index in Advanced Heart Failure: A New Index?
  120. Use and Misuse of Multivariable Approaches in Interventional Cardiology Studies on Drug-Eluting Stents: A Systematic Review
  121. Remote ischaemic preconditioning in coronary artery bypass surgery: a meta-analysis
  122. Drug-Eluting Stents
  123. Drug-eluting stents
  124. Changing of SYNTAX score performing fractional flow reserve in multivessel coronary artery disease
  125. Prevalence and non-invasive predictors of left main or three-vessel coronary disease: evidence from a collaborative international meta-analysis including 22 740 patients
  126. TIMI, GRACE and alternative risk scores in Acute Coronary Syndromes: A meta-analysis of 40 derivation studies on 216,552 patients and of 42 validation studies on 31,625 patients
  127. Prasugrel During Primary Percutaneous Coronary Intervention: Evidence from Clinical Data
  128. Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis
  129. PICKING THE BEST NOVEL ORAL ANTICOAGULANT FOR ATRIAL FIBRILLATION: EVIDENCE FROM A WARFARIN-CONTROLLED NETWORK META-ANALYSIS
  130. Potential Pitfalls of Meta-Analyses of Observational Studies in Cardiovascular Research
  131. 037 Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 32 studies, 222,752 patients, and 4490 thromboses
  132. Acute coronary syndromes in human immunodeficiency virus patients: a meta-analysis investigating adverse event rates and the role of antiretroviral therapy
  133. Novel insights on HIV/AIDS and cardiac disease: shedding light on the HAART of Darkness
  134. Agreement between adjusted indirect comparison and simplified network meta-analyses on prasugrel and ticagrelor (Reply to Passaro et al. — Int J Cardiol 2011)
  135. Comparison of Mortality Rates in Women Versus Men Presenting With ST-Segment Elevation Myocardial Infarction